Stereotaxis Reports 2016 First Quarter Financial Results
May 09, 2016 16:05 ET
|
Stereotaxis, Inc.
Ventricular tachycardia procedures increased 27% year over year, representing the third consecutive quarter of 20%+ volume growthFourth Niobe® system shipped to JapanPatient enrollment completed...
Stereotaxis to Highlight New Clinical Results and Automation Enhancements at Heart Rhythm 2016 in San Francisco May 4-7
May 04, 2016 09:00 ET
|
Stereotaxis, Inc.
ST. LOUIS, May 04, 2016 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NASDAQ:STXS), a global leader in innovative technologies for the treatment of cardiac arrhythmias, announced today that it will...
Stereotaxis to Report First Quarter 2016 Financial Results on May 9, 2016
May 02, 2016 09:00 ET
|
Stereotaxis, Inc.
ST. LOUIS, May 02, 2016 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NASDAQ:STXS), a global leader in innovative technologies for the treatment of cardiac arrhythmias, today announced that it will release...
Stereotaxis Awarded U.S. Patent for Vmotion Spotlight Automation Feature of Vdrive® Robotic Navigation System
April 29, 2016 09:00 ET
|
Stereotaxis, Inc.
ST. LOUIS, April 29, 2016 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NASDAQ:STXS), a global leader in innovative technologies for the treatment of cardiac arrhythmias, today announced that the U.S....
Lund University Hospital Study Validates Improved Long-Term Clinical Outcomes Using Stereotaxis Technology
April 07, 2016 09:00 ET
|
Stereotaxis, Inc.
ST. LOUIS, April 07, 2016 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NASDAQ:STXS), a global leader in innovative technologies for the treatment of cardiac arrhythmias, today announced the results of a...
U.S. Hospital Surpasses 1,000 Procedures using Stereotaxis Niobe® System
April 04, 2016 09:00 ET
|
Stereotaxis, Inc.
ST. LOUIS, April 04, 2016 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NASDAQ:STXS), a global leader in innovative technologies for the treatment of cardiac arrhythmias, today announced that the Hoffman...
Stereotaxis Completes Patient Enrollment for Niobe® System’s Post-Market Surveillance in Japan
March 30, 2016 09:00 ET
|
Stereotaxis, Inc.
ST. LOUIS, March 30, 2016 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NASDAQ:STXS), a global leader in innovative technologies for the treatment of cardiac arrhythmias, today announced that Takatsuki...
Centre Hospitalier Régional Universitaire de Nancy Strengthens Leadership in Cardiac Rhythm Management through Stereotaxis Technology
March 18, 2016 09:00 ET
|
Stereotaxis, Inc.
ST. LOUIS, March 18, 2016 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NASDAQ:STXS), a global leader in innovative technologies for the treatment of cardiac arrhythmias, today announced the first...
Journal of Cardiovascular Electrophysiology Publishes Special Issue Dedicated to Stereotaxis Technology
March 11, 2016 09:00 ET
|
Stereotaxis, Inc.
ST. LOUIS, March 11, 2016 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NASDAQ:STXS), a global leader in innovative technologies for the treatment of cardiac arrhythmias, today announced that the Journal...
Stereotaxis Reports 2015 Fourth Quarter and Full Year Financial Results
February 22, 2016 16:05 ET
|
Stereotaxis, Inc.
New capital orders of $5.1 million in the fourth quarter, including two Niobe® ES system orders in JapanFourth quarter free cash flow of $1.6 million, driving a 71% reduction in full year cash burn...